Streetbeat News

Revenues

LGND

Ligand Pharmaceuticals has reaffirmed its fiscal year 2024 adjusted earnings per share (EPS) guidance to be in the range of $4.25 to $4.75, compared to the consensus estimate of $4.44. The company also expects revenue to be between $130 million and $142 million, versus the estimated $137.680 million.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 9:23 pm

OLP

One Liberty Properties (OLP) reported Q1 FFO of $0.48 per share, meeting analyst estimates, with a 4% decrease from last year's $0.50. Quarterly sales were $22.70M, beating estimates by 2.10% but showing a 1.12% decrease from the previous year.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 9:23 pm

MBC

MasterBrand has reiterated its fiscal year 2024 expectations, forecasting a year-over-year net sales decline of a low single-digit percentage to flat, with an adjusted EPS range of $1.40 to $1.60, aligning with an estimated $1.45.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 9:22 pm

ASTH

Astrana Health has reaffirmed its financial outlook for 2024, projecting earnings per share (EPS) in the range of $1.28 to $1.52, compared to the estimated $1.51. The company also forecasts total revenue to be between $1.65 billion and $1.85 billion, versus the estimated $1.76 billion.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 9:21 pm

PEN

Penumbra has reaffirmed its fiscal year 2024 revenue forecast to be in the range of $1.230 billion to $1.270 billion, aligning closely with the analyst estimate of $1.246 billion.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 9:20 pm

LOPE

Grand Canyon Education provided its FY24 earnings and revenue guidance, expecting adjusted EPS to range between $7.57 and $8.04, compared to the estimated $7.65. Revenue projections are between $1.020 billion and $1.041 billion, against an estimate of $1.030 billion.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 9:18 pm

LOPE

Grand Canyon Education provided Q4 2024 earnings and revenue guidance, expecting adjusted EPS to be between $2.81 and $3.09, compared to the estimated $2.93. Revenue is anticipated to be between $287M and $299M, versus the estimated $294.467M.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 9:18 pm

APEI

American Public Education anticipates Q2 consolidated revenue between $153M-$155M, surpassing the estimated $150.125M. The EPS is projected to range from ($0.11) to $0.05, compared to the estimated $0.01.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 9:11 pm

ODD

ODDITY Tech has updated its FY24 financial outlook, raising EPS estimates from $1.49-$1.54 to $1.57-$1.62 and revenue forecasts from $620M-$630M to $626M-$635M. The company anticipates 23%-25% year-over-year revenue growth, a gross margin of 71.0%, and adjusted EBITDA between $139M-$143M. These adjustments reflect accelerated investments in growth initiatives, expected to impact adjusted EBITDA margin negatively in the latter half of 2024.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 9:07 pm

OPAD

Offerpad Solutions (NYSE:OPAD) received mixed analyst ratings over the past three months, with a shift towards a more cautious outlook in the last 30 days. The average 12-month price target for OPAD has been lowered to $8.6 from $9.25, indicating a negative sentiment shift. Analysts from firms including JMP Securities and Goldman Sachs have adjusted their price targets and ratings, reflecting concerns over Offerpad's market performance, revenue decline of -64.49%, and financial metrics such as net margin and ROE which, despite being strong, are set against a backdrop of challenging revenue growth and market capitalization issues.

Portfolio Pulse from Benzinga Insights

May 07, 2024 | 9:02 pm